Epiandrosterone

Epiandrosterone

SCHEMBL295167

C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 5/20 1.00
GPBAR1 Q8TDU6 4/20 1.00
LMNA P02545 3/20 1.00
CYP3A4 P08684 3/20 1.00
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
SHBG P04278 2/20 1.00
SERPINA6 P08185 2/20 1.00
MAPK1 P28482 2/20 1.00
HSD17B3 P37058 1/20 1.00
PMP22 Q01453 1/20 1.00
AKR1B10 O60218 1/20 1.00
AKR1B1 P15121 1/20 1.00
CYP2D6 P10635 1/20 1.00
TSHR P16473 1/20 1.00
NFKB1 P19838 1/20 1.00
CYP2C19 P33261 1/20 1.00
ALDH1A1 P00352 1/20 0.67
TP53 P04637 1/20 0.67
MAPT P10636 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Androsterone SCHEMBL10273502 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL269982 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL13175783 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL12811704 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL15426610 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL23031469 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL9940929 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL19750468 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL21114416 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL15963588 1.00 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2350 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243291-A1 PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES GENENTECH, INC. (US) 2025-07-31 US claimed
CN-119954881-A Preparation method of epiandrosterone 厦门嘉氢科技有限公司 2025-05-09 CN claimed
CN-119355175-B Method for non-targeted detection of 86 hormone interferents in aquatic ecosystem, hormone interferent ecological risk evaluation method and optimal control sequencing method 成都市食品检验研究院 2025-04-29 CN claimed
US-12280021-B2 Affinity medicant conjugate AF CHEMICALS, LLC (US) 2025-04-22 US claimed
CN-118530293-B Preparation method of epiandrosterone 湖北武当安泰药业有限公司 2025-04-08 CN claimed
CN-119638768-A Preparation method of dihydrotestosterone and intermediate thereof 湖北竹溪人福药业有限责任公司 2025-03-18 CN claimed
CN-119591653-A Synthesis method of 5 alpha-androstane-2-alkene-17-ketone 上海药坦药物研究开发有限公司 2025-03-11 CN claimed
EP-4365189-B1 PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES HOFFMANN LA ROCHE (CH) 2025-02-19 EP claimed
CN-119355175-A Method for non-targeted detection of 86 hormone interferents in aquatic ecosystem, hormone interferent ecological risk evaluation method and optimal control sequencing method 成都市食品检验研究院 2025-01-24 CN claimed
CN-119306662-A Method for constructing molten pyridine compound by copper-catalyzed [2+1+3] cyclization reaction of cyclic ketone with alpha, beta-unsaturated aldehyde/ketone and ammonium iodide 湖南大学 2025-01-14 CN claimed
US-5846961-A Multi-faceted method to repress reproduction of latent viruses in humans and animals HIV DIAGNOSTICS, INC. (US) 1998-12-08 US claimed
WO-1998046233-A1 OSTEOBLAST-PROMOTING PHARMACEUTICAL COMPOSITION COMPRISING A CARNITINE COMPOUND AND DHEA OR DHEA-S SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1998-10-22 WO claimed
US-5817803-A Process for preparing neuromuscular blocking agents and intermediates useful therefor POLI INDUSTRIA CHIMICA, S.P.A. (IT) 1998-10-06 US claimed
US-5808051-A Process for preparing neuromuscular blocking agents and intermediates useful therefor POLI INDUSTRIA CHIMICA, S.P.A. (IT) 1998-09-15 US claimed
CN-1175903-A Method of treating adenosine depletion UNIV EAST CAROLINA (US) 1998-03-11 CN claimed
EP-0784471-A4 MULTI-FACETED METHOD TO REPRESS REPRODUCTION OF LATENT VIRUSES IN HUMANS AND ANIMALS DYKE KNOX VAN (US) 1997-11-19 EP claimed
EP-0784471-A2 MULTI-FACETED METHOD TO REPRESS REPRODUCTION OF LATENT VIRUSES IN HUMANS AND ANIMALS Van Dyke, Knox (US) 1997-07-23 EP claimed
WO-1996010402-A1 MULTI-FACETED METHOD TO REPRESS REPRODUCTION OF LATENT VIRUSES IN HUMANS AND ANIMALS DYKE KNOX VAN (US) 1996-04-11 WO claimed
US-5276132-A Polyamic acid or polyimide having a steroidal skeleton providing a pretilt angle of 3 to 90 degrees; SBE(super twisted birefringence effect) and SH(super homeotropic) devices JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1994-01-04 US claimed
CN-1068122-A Synthesis of protein assimilating hormone, and 17 beta-hydroxyl-17 alphas-methyl androstane alkane (3,2-C)-the pyrazoles method NANNING PHARMACEUTICAL ENTERPR (CN) 1993-01-20 CN claimed